Therapeutic Applications of Antisense Oligonucleotides in Asthma and Allergy

被引：1

作者：

Isidoro-Garcia, Maria ^{[1
,2
]}

Davila, Ignacio ^{[2
]}

机构：

[1] Univ Hosp Salamanca, Dept Clin Biochem, Paseo San Vicente S-N, Salamanca 37008, Spain

[2] Univ Hosp Salamanca, Dept Allergy, Salamanca, Spain

来源：

RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY | 2007年 / 1卷 / 03期

关键词：

Allergy; antisense oligonucleotides; AS-ON; asthma; respirable antisense oligonucleotide;

D O I：

10.2174/187221307782418838

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Antisense oligonucleotides represent a novel therapeutic approach for manipulation of gene expression in the treatment of respiratory diseases. This methodology is based on the use of synthetic oligonucleotides to inhibit the expression of a specific target gene by inhibiting the function of the corresponding messenger RNA. Inhaled antisense oligonucleotides are therapeutic alternatives in the treatment of respiratory diseases including allergic asthma; however development of this technology is at an early stage and critical questions related to design, biological activity, and target delivery still remain. The present review will discuss the current status of antisense technology and its application in asthma and allergy. It will be focused in some representative patents including considerations on the future clinical prospects.

引用

页码：171 / 175

页数：5

共 46 条

[1]

Agrawal S., 2006, WO, Patent No. 06053090A2

[2] Absorption, distribution, metabolism, and excretion of a respirable antisense oligonucleotide for asthma [J].

Ali, S ;

Leonard, SA ;

Kukoly, CA ;

Metzger, WJ ;

Wooles, WR ;

McGinty, JF ;

Tanaka, M ;

Sandrasagra, A ;

Nyce, JW .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 163 (04) :989-993

[3] Inhibition of GM-CSF/IL-3/IL-5 signaling by antisense oligodeoxynucleotides targeting the common beta chain of their receptors [J].

Allam, M ;

Renzi, PM .

ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 2001, 11 (05) :289-300

[4]

Baker B. F., 2002, WO, Patent No. 0020645A1

[5]

Ball Howard A, 2003, Am J Pharmacogenomics, V3, P97, DOI 10.2165/00129785-200303020-00003

[6] Mac-1 (CDllb/CD18) is an oligodeoxynucleotide-binding protein [J].

Benimetskaya, L ;

Loike, JD ;

Khaled, Z ;

Loike, G ;

Silverstein, SC ;

Cao, L ;

Khoury, JE ;

Cai, TQ ;

Stein, CA .

NATURE MEDICINE, 1997, 3 (04) :414-420

[7] CHARACTERIZATION OF RIBONUCLEASE-H ACTIVITIES PRESENT IN 2 CELL-FREE PROTEIN SYNTHESIZING SYSTEMS, THE WHEAT-GERM EXTRACT AND THE RABBIT RETICULOCYTE LYSATE [J].

CAZENAVE, C ;

FRANK, P ;

BUSEN, W .

BIOCHIMIE, 1993, 75 (1-2) :113-122

[8] POLYALKYLCYANOACRYLATE NANOPARTICLES AS POLYMERIC CARRIERS FOR ANTISENSE OLIGONUCLEOTIDES [J].

CHAVANY, C ;

LEDOAN, T ;

COUVREUR, P ;

PUISIEUX, F ;

HELENE, C .

PHARMACEUTICAL RESEARCH, 1992, 9 (04) :441-449

[9]

CLARENC JP, 1993, ANTI-CANCER DRUG DES, V8, P81

[10] Progress in antisense technology [J].

Crooke, ST .

ANNUAL REVIEW OF MEDICINE, 2004, 55 :61-95

← 1 2 3 4 5 →